Sponsor Dossier
Pfizer (Perth)
Sponsor Dossier for Pfizer (Perth). ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: Aciclovir Intravenous Infusion
- Brand: Atropine
- Brand: Bupivacaine Injection BP
- Brand: Carboplatin Injection
- Brand: Chlorhexidine
- Brand: Cisplatin Injection
- Brand: Cytarabine Injection
- Brand: Daunorubicin Injection
About
Pfizer (Perth) is an Australian Private Company with ABN 32051824956, registered in Western Australia. The company is currently active.
Portfolio
Pfizer (Perth) has 29 brands on the ARTG, of which 4 are indexable and 0 carry a Product Information document. 4 brands are PBS-listed, 0 have a PBAC outcome on record, and 0 have an AusPAR on record. Notable brands include Aciclovir Intravenous Infusion, Atropine, Bupivacaine Injection BP, Carboplatin Injection, Chlorhexidine, Cisplatin Injection, Cytarabine Injection, Daunorubicin Injection, Docetaxel Pfizer, Doxorubicin, Epirubicin, Etoposide.
Therapeutic focus
— Oncology: 14 brands — Infectious Disease: 4 brands — Other: 3 brands — Pain Management: 2 brands — Haematology: 2 brands — Cardiology: 1 brand — Neurology: 1 brand — Dermatology: 1 brand — Gastroenterology: 1 brand
PBS footprint
4 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.